中药三甲益肝冲剂预防鼠肝纤维化
肝硬化,治疗;三甲益肝冲剂;疾病模型,动物;肝,病理学,*河南省教委资助课题,No.96320029.,项目负责人,*SubjectsupportedbytheHenanProvincialEdacationcommittee,No.96320029,Correspondenceto,PreventiveeffectofSanjiaYigangranuleinhepatof
新乡医学院第一附属医院传染科 河南省卫辉市 453100申保生,男,1965-02-22生,河南省林州市人,汉族. 1988年新乡医学院毕业,传染科主治医师,讲师.
*河南省教委资助课题,No.96320029.
项目负责人 申保生,453100,新乡医学院第一附属医院传染科,河南省卫辉市学院路.
*Subject supported by the Henan Provincial Edacation committee,No.96320029
Correspondence to Bao-Sheng Shen, Department of Infectious Diseases, the First Affiliated Hospital of Xinxiang Medical College, Weihui 453100, Henan Province, China
Tel. +86·373·4402690
收稿日期 1997-10-28
Preventive effect of Sanjia Yigan granule in hepatofibrosis in rats*
Bao-Sheng Shen, Xiao-Gang Wong, Han-Chen Qiao, Zhao-Hui Lu,Qing Han, Wei Wang and Hui-Ling Guan
Department of Infectious Diseases, the First Affiliated Hospital of Xinxiang Medical College, Weihui 453100, Henan Province, China
Abstract
AIM To study the preventive effect of Sanjia Yigan granule in experimental hepatofibrosis in rats.
METHODS The experimental hepatofibrosis rats produced by CCl4 were treated with Sanjia Yigan granuleig, and the results were compared with control groups prevented with hepatocyte growth-promoting factors (pHGF) and Dahuang Zhechong pills. The serum hepatofibrosis indexes, hyaluronic acid (HA), collagen Ⅳ (Ⅳ-C) and laminin (LN) were measured with radioimmunoassay, and the liver pathological changes were observed in each group of rats. The results were analyzed statistically. ......
您现在查看是摘要页,全文长 11956 字符。